| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human Long-chain-fatty-acid--CoA ligase 5 |
|---|
| Description | 33-683aa; Cytoplasmic Domain. MW: 76.42kD. Purity >90% as determined by SDS-PAGE. Acyl-CoA synthetases (ACSL) activate long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. ACSL5 may activate fatty acids from exogenous sources for the synthesis of triacylglycerol destined for intracellular storage (By similarity). Utilizes a wide range of saturated fatty acids with a preference for C16-C18 unsaturated fatty acids (By similarity). It was suggested that |
|---|
| Size | 0.01 mg (E-Coli), 0.05 mg (E-Coli), 0.1 mg (E-Coli), 0.2 mg (E-Coli), 0.5 mg (E-Coli) |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [Long-chain acyl-CoA synthetase 5; LACS 5] |
|---|
| Gene, Accession, CAS # | ACSL5, Gene ID: 51703, Accession: NP_057318.2 |
|---|
| Catalog # | MBS1345515 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human Long-chain-fatty-acid--CoA ligase 5 from MYBIOSOURCE INC. |
|---|
| Product Specific References | Regulation of enterocyte apoptosis by acyl-CoA synthetase 5 splicing.Gassler N., Roth W., Funke B., Schneider A., Herzog F., Ehemann V., Sykora J., Haas T.L., Walczak H., Ganten T., Zentgraf H., Erb P., Alonso A., Autschbach F., Schirmacher P., Knuechel R., Kopitz J.Gastroenterology 133:587-598(2007) |
|---|
| 产品资料 |
|
|